E2F1 and ovarian carcinoma: We compared E2F1 expression levels in 59 cases of type I tumors and 17 normal ovarian tissues, and E2F1 expression was significantly elevated in the ovarian carcinoma tissues and was positively associated with FIGO stage I–II and III–IV disease.